# OMISIRGE

NDC: 73441-800
Generic name: omidubicel-onlv
Labeler / Manufacturer: Gamida Cell Inc.
Product type: CELLULAR THERAPY
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20230501

FDA application: BLA125738

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73441-800"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73441-800
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=979803c9-956c-42e7-9d75-c37cc4e90632